CDC detects new COVID-19 variant BA.2.86
Background: Viruses, including the one responsible for COVID-19 (SARS-CoV-2), naturally evolve, leading to the emergence of "variants." These variations can influence transmissibility, treatment responsiveness and disease severity. Recently, a novel variant, BA.2.86, was identified in Denmark and Israel. Notably, it exhibits distinct genetic differences from earlier SARS-CoV-2 versions. This variant has been detected in the United States as well.
Current Risk Assessment:
• Existing Detection and Treatment: Current tests and medications used for COVID-19 seem effective against BA.2.86.
• Infectiousness: BA.2.86 might have a higher potential to infect individuals who've previously had COVID-19 or have been vaccinated.
• Updated Vaccine: Scientists are evaluating the effectiveness of the forthcoming, updated COVID-19 vaccine. CDC anticipates that it will reduce severe illness and hospitalization.
• Disease Severity: Presently, no evidence indicates increased severity from this variant. However, it is early in the emergence of this variant, and further monitoring is needed to evaluate impacts.
Preventive Measures:
• Vaccination: Continue getting vaccinated and consider updated vaccines when recommended.
• Hygiene: Practice good hand hygiene and maintain respiratory etiquette.
• Masking: Wear masks, especially in crowded or indoor settings, as advised.
• Isolate: If feeling sick, stay home and self-isolate.
• Avoid Crowds: Minimize exposure to large gatherings.
• Stay Informed: Rely on reputable sources like the CDC for accurate information.
Stay vigilant, stay informed, and prioritize your health. CDC is committed to sharing updates as new insights emerge.
Take a deeper dive and view the CDC's full assessment here: https://www.cdc.gov/respiratory-viruses/whats-new/covid-19-variant.html